| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.03▲ | 1.03▲ | 1.03▲ | 1.02▲ | 1.05▼ |
| MA10 | 1.03▲ | 1.04▲ | 1.04▲ | 1.03▲ | 1.18▼ |
| MA20 | 1.04▲ | 1.04▲ | 1.04▲ | 1.08▼ | 1.33▼ |
| MA50 | 1.04▲ | 1.08▼ | 1.11▼ | 1.25▼ | 1.83▼ |
| MA100 | 1.11▼ | 1.16▼ | 1.19▼ | 1.38▼ | 1.99▼ |
| MA200 | 1.19▼ | 1.28▼ | 1.32▼ | 1.77▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.003▲ | 0.005▲ | 0.007▲ | -0.016▼ |
| RSI | 54.040▲ | 46.836▼ | 45.030▼ | 38.458▼ | 33.921▼ |
| STOCH | 16.667▼ | 11.111▼ | 33.611 | 50.502 | 8.298▼ |
| WILL %R | 0.000▲ | -33.333 | -20.000▲ | -59.947 | -87.143▼ |
| CCI | 91.441 | 16.092 | 54.088 | -1.765 | -101.154▼ |
|
Friday, October 16, 2026 08:20 AM
ImmunityBio has secured early FDA label expansion for Anktiva in BCG-unresponsive NMIBC. Check out why IBRX stock is a hold.
|
|
Wednesday, October 14, 2026 01:18 PM
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved indication for ANKTIVA® ...
|
|
Sunday, June 07, 2026 05:00 PM
Agilent Technologies Inc. (NYSE: A) announced a collaboration with OpenAI and Boston Consulting Group (BCG) to accelerate the deployment of artificial intelligence (AI) across the company’s products, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/10/26 | 1.02 | 1.065 | 1.02 | 1.04 | 39,689 |
| 16/10/26 | 1.0301 | 1.0301 | 1.02 | 1.02 | 5,409 |
| 15/10/26 | 1.015 | 1.035 | 1.015 | 1.03 | 4,503 |
| 14/10/26 | 1.00 | 1.02 | 0.9977 | 1.00 | 26,811 |
| 13/10/26 | 1.01 | 1.04 | 0.9999 | 1.02 | 10,157 |
| 12/10/26 | 1.03 | 1.035 | 1.01 | 1.03 | 18,909 |
| 09/10/26 | 1.07 | 1.07 | 1.0321 | 1.05 | 3,020 |
| 08/10/26 | 0.99 | 1.06 | 0.95 | 1.045 | 30,596 |
| 07/10/26 | 1.03 | 1.0352 | 0.9701 | 0.9907 | 22,921 |
| 06/10/26 | 1.03 | 1.07 | 1.025 | 1.05 | 6,787 |
|
|
||||
|
|
||||
|
|